DE602005013382D1 - Feste formen des magnesiumsalzes von (s)-omeprazol und verfahren zu deren herstellung - Google Patents

Feste formen des magnesiumsalzes von (s)-omeprazol und verfahren zu deren herstellung

Info

Publication number
DE602005013382D1
DE602005013382D1 DE602005013382T DE602005013382T DE602005013382D1 DE 602005013382 D1 DE602005013382 D1 DE 602005013382D1 DE 602005013382 T DE602005013382 T DE 602005013382T DE 602005013382 T DE602005013382 T DE 602005013382T DE 602005013382 D1 DE602005013382 D1 DE 602005013382D1
Authority
DE
Germany
Prior art keywords
magnesium salt
omeprazole
solid forms
solvent
omeprazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005013382T
Other languages
English (en)
Inventor
Maimo Ramon Berenguer
Laura Coppi
Guillen Yolanda Gasanz
Ruperez Jorge Medrano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Quimica SA
Original Assignee
Esteve Quimica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica SA filed Critical Esteve Quimica SA
Publication of DE602005013382D1 publication Critical patent/DE602005013382D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602005013382T 2004-07-02 2005-06-29 Feste formen des magnesiumsalzes von (s)-omeprazol und verfahren zu deren herstellung Active DE602005013382D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200401729A ES2246149B1 (es) 2004-07-02 2004-07-02 Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
PCT/EP2005/053062 WO2006003163A1 (en) 2004-07-02 2005-06-29 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation

Publications (1)

Publication Number Publication Date
DE602005013382D1 true DE602005013382D1 (de) 2009-04-30

Family

ID=34972307

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005013382T Active DE602005013382D1 (de) 2004-07-02 2005-06-29 Feste formen des magnesiumsalzes von (s)-omeprazol und verfahren zu deren herstellung

Country Status (19)

Country Link
US (1) US7902370B2 (de)
EP (1) EP1765807B1 (de)
JP (2) JP5575366B2 (de)
KR (1) KR101290035B1 (de)
CN (1) CN1976923B (de)
AT (1) ATE425975T1 (de)
AU (1) AU2005259205B2 (de)
CA (1) CA2570559C (de)
CY (1) CY1109048T1 (de)
DE (1) DE602005013382D1 (de)
DK (1) DK1765807T3 (de)
ES (2) ES2246149B1 (de)
HR (1) HRP20090211T1 (de)
MX (1) MXPA06014736A (de)
NO (1) NO20070635L (de)
NZ (1) NZ552458A (de)
PT (1) PT1765807E (de)
WO (1) WO2006003163A1 (de)
ZA (1) ZA200700865B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2147918A1 (de) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form
CN103044400A (zh) * 2012-12-21 2013-04-17 北京华禧联合科技发展有限公司 埃索美拉唑镁盐及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
CN1138534C (zh) * 1994-07-08 2004-02-18 阿斯特拉曾尼卡有限公司 多单元片剂
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
AU777667B2 (en) * 1999-08-26 2004-10-28 Aaipharma Incorporated Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) * 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
BR0110926A (pt) * 2000-05-15 2004-02-17 Ranbaxy Lab Ltd Novas formas amorfas de sais de omeprazol e processo de preparação dos mesmos
CA2386716C (en) * 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
AU2001276721A1 (en) * 2000-08-04 2002-02-18 Takeda Chemical Industries Ltd. Salts of benzimidazole compound and use thereof
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
AU2003262375A1 (en) 2002-04-22 2003-11-03 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
US7612098B2 (en) 2002-08-30 2009-11-03 Dr. Reddy's Laboratories Limited Amorphous hydrous esomeprazole magnesium
AU2003278406A1 (en) 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
US20040242642A1 (en) * 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
AU2003238671A1 (en) * 2003-04-10 2004-11-01 Hetero Drugs Limitd Novel crystalline forms of s-omeprazole magnesium
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.

Also Published As

Publication number Publication date
CA2570559C (en) 2012-08-28
ZA200700865B (en) 2009-09-30
US7902370B2 (en) 2011-03-08
CY1109048T1 (de) 2014-07-02
US20070249684A1 (en) 2007-10-25
NO20070635L (no) 2007-03-20
CA2570559A1 (en) 2006-01-12
CN1976923A (zh) 2007-06-06
PT1765807E (pt) 2009-04-13
ES2323319T3 (es) 2009-07-13
WO2006003163A1 (en) 2006-01-12
ES2246149B1 (es) 2007-06-01
KR20070031992A (ko) 2007-03-20
MXPA06014736A (es) 2007-06-25
ES2246149A1 (es) 2006-02-01
CN1976923B (zh) 2011-08-24
EP1765807A1 (de) 2007-03-28
DK1765807T3 (da) 2009-06-08
AU2005259205A1 (en) 2006-01-12
EP1765807B1 (de) 2009-03-18
JP2014169302A (ja) 2014-09-18
HRP20090211T1 (en) 2009-05-31
AU2005259205B2 (en) 2011-01-27
JP5575366B2 (ja) 2014-08-20
ATE425975T1 (de) 2009-04-15
NZ552458A (en) 2010-07-30
JP2008505160A (ja) 2008-02-21
KR101290035B1 (ko) 2013-07-30

Similar Documents

Publication Publication Date Title
BR9407655A (pt) Método para a produçao de steres cíclicos T
ATE244280T1 (de) Transxanthophyllesterkonzenrate von erhöhter reinheit und verfahren zu deren herstellung
Chavan et al. Efficient and mild method for preparation of allylic amines from aziridine-2-alcohols using PPh3/I2/imidazole
DE602005013382D1 (de) Feste formen des magnesiumsalzes von (s)-omeprazol und verfahren zu deren herstellung
DE602004032578D1 (de) Verbessertes verfahren zur herstellung von chlorierter saccharose
JP2015083600A (ja) Ｎ−ビニルアミドから副生成物を除去する方法
DE60306622D1 (de) Verfahren zur herstellung von ascorbinsäure
DE50104094D1 (de) Verfahren zur Herstellung von reinem Triethylendiamin (TEDA)
ATE403658T1 (de) Verfahren zur herstellung einer lösung von reinem triethylendiamin (teda)
ATE541852T1 (de) Verfahren zur herstellung von maltitangereicherten produkten
NO20076590L (no) Fremgangsmate og innretning for a fremstille en etanol/vann blanding
CN109053528B (zh) 一种左乙拉西坦的合成工艺
ATE495166T1 (de) Verbessertes verfahren zur zubereitung von rabeprazol-natrium
WO2007092705A3 (en) Process for preparing gemcitabine and associated intermediates
EP3507274B1 (de) Verfahren zur herstellung chiraler aminonitrile
CN107337628B (zh) 一种制备左乙拉西坦的方法
CN106699724B (zh) 一种自合成母液中回收盐酸阿替卡因或其中间产物的方法
Balgotra et al. Direct C–N bond cleavage of N-vinyl or N-allyl arylamines: a metal-free strategy for N-devinylation and N-deallylation
JP2005509011A5 (de)
CN103896819B (zh) 一种(s)-1-氯乙酰基吡咯烷-2-甲酰胺的制备方法
RU2794748C1 (ru) Синтез (1r,2s,5s)-n-[(1s)-1-циано-2-[(3s)-2-оксопирролидин-3-ил]этил]-3-[(2s)-3,3-диметил-2-[(2,2,2-трифторацетил)амино]бутаноил]-6,6-диметил-3-азабицикло[3.1.0]гексан-2-карбоксамида
RU2794750C1 (ru) Способ получения (1r,2s,5s)-n-[(1s)-1-циано-2-[(3s)-2-оксопирролидин-3-ил]этил]-3-[(2s)-3,3-диметил-2-[(2,2,2-трифторацетил)амино]бутаноил]-6,6-диметил-3-азабицикло[3.1.0]гексан-2-карбоксамида
AR002510A1 (es) Un procedimiento para la preparacion de derivados de 1-(3-trialquilsilil- fenil)-2,2,2-trifluorometiletanona que son utiles en el tratamiento de laenfermedad de alzheimer y demencia senil y procedimiento para la purificacion de dicho derivado con dicho procedimiento de preparacion.
EP3214075A3 (de) Ein sicheres und effizientes verfahren zur herstellung von carmustin
WO2023200364A1 (ru) Способы получения (1r,2s,5s)-n-[(1s)-1-циано-2-[(3s)-2-оксопирролидин-3-ил]этил]-3-[(2s)-3,3-диметил-2-[(2,2,2-трифторацетил)амино]бутаноил]-6,6-диметил-3-азабицикло[3.1.0]гексан-2-карбоксамида

Legal Events

Date Code Title Description
8364 No opposition during term of opposition